secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moleculin Biotech, Inc. (MBRX)
CIK:        0001659617
Form:       8-K
Filed at:   2026-02-05T23:59:59+00:00
Accession:  0001437749-26-003119
Event type: other
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Moleculin Biotech shareholders approve warrant share issuance, reject name change to Moleculin Inc.
--------------------------------------------------------------------------------

- Approved issuance of up to 2,610,823 shares upon exercise of warrants issued Dec 11, 2025; 578,385 For, 68,176 Against.
- Name change amendment from Moleculin Biotech, Inc. to Moleculin Inc. failed: 1,124,921 For (needed >1,346,766 majority of outstanding shares).
- Adjournment proposal approved (582,534 For, 64,190 Against) to allow further proxy solicitation if needed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659617/000143774926003119/0001437749-26-003119-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659617/000143774926003119/mbrx20260204_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-003119

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer